Latest On-Demand Webinars

In this webinar, speakers from PACT Pharma Inc. and Thermo Fisher Scientific discuss how modular instrumentation platforms can enable automation and standardization of the end-to-end manufacturing workflow, from cell isolation and activation to genetic modification and expansion.

Nelly Lourenço, from DNA Script will discuss how oligos on demand can accelerate innovation by effectively enabling assembly of the full 720bp GFP gene using EDS oligos via polymerase chain assembly.

This presentation will highlight our recent progress in the discovery of N-glycans and phospholipids that significantly contribute to aberrant cancer metabolic pathways in primary tumors and metastases. We have also developed novel MALDI imaging approaches of drugs and drug metabolites that exploit key metabolic differences in tumors.

Join us for an invigorating spatial discussion, where we show the latest data using the PhenoCycler™-Fusion system, the fastest single-cell spatial biology solution.

In this webinar you will learn how the power of large-scale proteomics can be leveraged for multiple divergent applications in the field of oncology.

The global market for antibody therapeutics is rising rapidly and newer, engineered modalities such as bi-specific antibodies and antibody fragments are entering clinical studies in record number

Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and several FDA approved products already on the market.

In this webinar, Dr. Kristin G. Anderson, Research Associate from the Greenberg lab at the Fred Hutchinson Cancer Research Center, discusses engineering T cells to improve survival in the immunosuppressive tumor microenvironment.

Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.

Most in vitro, well-plate biological experiments require a media change every day or two, with cyclic variations in nutrient and metabolite concentrations leading to physiologically unrealistic gene expression and metabolism.